Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Geophagy and Knowledge About Its Health Effects Among Native Sub-Saharan Africa, Caribbean and South America Healthy Adults Living in France (Prevalgeophagy)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03948126
Recruitment Status : Completed
First Posted : May 13, 2019
Last Update Posted : May 13, 2019
Sponsor:
Information provided by (Responsible Party):
CHU de Reims

Brief Summary:
Since geophagy is widespread among women from Sub-Saharan Africa, South America and the Caribbean, we aimed to determine the frequency of geophagy and the level of knowledge about its health effects among healthy adults originating from these countries and attending a travel medicine and international vaccination consultation in France.

Condition or disease Intervention/treatment
Geophagia Other: Questionnaire about geophagia (knowledge about soil/clay consumption and knowledge of the health effects of geophagy)

Detailed Description:

Since geophagy is widespread among women from Sub-Saharan Africa, South America and the Caribbean, we aimed to determine the frequency of geophagy and the level of knowledge about its health effects among healthy adults originating from these countries and attending a travel medicine and international vaccination consultation in France.

A cross-sectional study was performed in the consultation for travel medicine and international vaccination in Reims University Hospital, France. All adult travellers who were natives of Sub Saharan Africa, South America and the Caribbean or born in France of parents from these countries were eligible to complete a confidential questionnaire about geophagy, which was defined as eating soil or clay. Descriptive analysis was performed.

Layout table for study information
Study Type : Observational
Actual Enrollment : 101 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Prevalence of Geophagy and Knowledge About Its Health Effects Among Native Sub-Saharan Africa, Caribbean and South America Healthy Adults Living in France
Actual Study Start Date : April 1, 2015
Actual Primary Completion Date : September 1, 2016
Actual Study Completion Date : September 1, 2016

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
travel medicine
Healthy adults originating from Sub-Saharan Africa, South America and the Caribbean and attending a travel medicine and international vaccination consultation in France.
Other: Questionnaire about geophagia (knowledge about soil/clay consumption and knowledge of the health effects of geophagy)



Primary Outcome Measures :
  1. Prevalence of geophagia [ Time Frame: Day 0 ]
    percentage of adults with geophagia


Secondary Outcome Measures :
  1. Awareness about iron-deficient anaemia [ Time Frame: Day 0 ]
    percentage of awareness about iron-deficient anaemia

  2. Awareness about soil-transmitted intestinal parasitic infections [ Time Frame: Day 0 ]
    percentage of awareness about soil-transmitted intestinal parasitic infections

  3. Awareness about constipation [ Time Frame: Day 0 ]
    percentage of awareness about constipation

  4. Awareness about intestinal occlusion [ Time Frame: Day 0 ]
    percentage of awareness about intestinal occlusion



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Healthy adults originating from Sub-Saharan Africa, South America and the Caribbean and attending a travel medicine and international vaccination consultation in France.
Criteria
inclusion criteria : All adult travellers who were natives of Sub Saharan Africa, South America and the Caribbean or born in France of parents from these countries

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03948126


Locations
Layout table for location information
France
Damien JOLLY
Reims, France
Sponsors and Collaborators
CHU de Reims
Publications:
Layout table for additonal information
Responsible Party: CHU de Reims
ClinicalTrials.gov Identifier: NCT03948126    
Other Study ID Numbers: 2018Ao007
First Posted: May 13, 2019    Key Record Dates
Last Update Posted: May 13, 2019
Last Verified: May 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by CHU de Reims:
geophagia
Additional relevant MeSH terms:
Layout table for MeSH terms
Pica
Signs and Symptoms, Digestive
Feeding and Eating Disorders
Mental Disorders